Cerevance
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications (NCT06553027) | Cerevance | 2024-09-20 |
| Phase 1 SAD/MAD Study of CVN766 in Healthy Volunteers (NCT05105243) | Cerevance | 2022-01-17 |
Track Cerevance automatically
Every clearance here is in the API, with alerts when new ones post.